|
|
||||||||
Ann Thorac Surg 1993;55:1418-1424
© 1993 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery and Department of Pathology, Washington University School of Medicine, St. Louis, Missouri USA
* Address reprint requests to Dr Kouchoukos, Department of Surgery, The Jewish Hospital of St. Louis, 216 S Kingshighway, St. Louis, MO 63110.
High-dose aprotinin was used in 20 patients undergoing primary or repeat operations on the thoracic or thoracoabdominal aorta using cardiopulmonary bypass and hypothermic circulatory arrest. The activated clotting times immediately before the establishment of hypothermic circulatory arrest exceeded 700 seconds in all but 1 patient. Three patients (15%) required reoperation for bleeding. Seven patients died during hospitalization, and 5 had postmortem examination. Platelet-fibrin thrombi were present in multiple organs including the coronary arteries of 4 patients with myocardial infarction or failure, the pulmonary arteries of 2 patients, 1 of whom died of acute right ventricular failure, the brains of 2 patients who sustained a stroke, and the kidneys of 4 patients, 3 of whom had development of renal dysfunction. Renal dysfunction occurred in 13 patients (65%), and all were 65 years of age or older. Five of these patients required hemodialysis. Among 20 age-matched patients who had similar operations without aprotinin, there was one hospital death (5%) from myocardial infarction, and renal dysfunction developed in 1 patient (5%), who did not require dialysis. None of these 20 patients required reoperation for bleeding. Although aprotinin has been shown to reduce blood loss in patients having cardiac operations employing cardiopulmonary bypass, this benefit was not attained in this group of patients with thoracic aortic disease in whom hypothermic circulatory arrest was used. Use of aprotinin in elderly patients undergoing these procedures was associated with an increased risk of renal dysfunction and failure, and of myocardial infarction and death.
This article has been cited by other articles:
![]() |
R. A. Jonas Aprotinin and pediatric heart surgery: children are not small adults Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, April 1, 2011; 8(2): 76 - 80. [Abstract] [PDF] |
||||
![]() |
S. K. Pasquali, M. Hall, J. S. Li, E. D. Peterson, J. Jaggers, A. J. Lodge, J. P. Jacobs, M. L. Jacobs, and S. S. Shah Safety of Aprotinin in Congenital Heart Operations: Results from a Large Multicenter Database Ann. Thorac. Surg., July 1, 2010; 90(1): 14 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Iwata, T. Okamura, N. Ishibashi, D. Zurakowski, H. G.W. Lidov, and R. A. Jonas Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1521 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Sundt The demise of aprotinin: Our share of the blame. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 729 - 731. [Full Text] [PDF] |
||||
![]() |
S. Westaby Aprotinin: Twenty-five years of claim and counterclaim J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 487 - 491. [Full Text] [PDF] |
||||
![]() |
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture Card. Surg. Adult, January 1, 2008; 3(2008): 753 - 784. [Full Text] |
||||
![]() |
G. J. Arnaoutakis, A. Bihorac, T. D. Martin, P. J. Hess Jr, C. T. Klodell, A. A. Ejaz, C. Garvan, C. G. Tribble, and T. M. Beaver RIFLE criteria for acute kidney injury in aortic arch surgery. J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1554 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Van der Linden, J.-F. Hardy, A. Daper, A. Trenchant, and S. G. De Hert Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome? Br. J. Anaesth., November 1, 2007; 99(5): 646 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G.T. Augoustides Fatal intraoperative thrombosis in contemporary adult thoracic aortic surgery requiring deep hypothermic circulatory arrest: Observations from the literature, 1993-2006. J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 1069 - 1070. [Full Text] [PDF] |
||||
![]() |
C. I. Coleman, V. T. Rigali, J. Hammond, J. Kluger, K. W. Jeleniowski, and C. M. White Evaluating the safety implications of aprotinin use: The Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS) J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1547 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hogue and M. J. London Aprotinin's Effect on ACT is Not an Artifact Anesth. Analg., May 1, 2007; 104(5): 1302 - 1303. [Full Text] [PDF] |
||||
![]() |
S. C. Body and C. D. Mazer Pro: Aprotinin Has a Good Efficacy and Safety Profile Relative to Other Alternatives for Prevention of Bleeding in Cardiac Surgery Anesth. Analg., December 1, 2006; 103(6): 1354 - 1359. [Full Text] [PDF] |
||||
![]() |
C. W. Hogue and M. J. London Aprotinin Use During Cardiac Surgery: A New or Continuing Controversy? Anesth. Analg., November 1, 2006; 103(5): 1067 - 1070. [Full Text] [PDF] |
||||
![]() |
A. Sedrakyan, A. Wu, G. Sedrakyan, M. Diener-West, M. Tranquilli, and J. Elefteriades Aprotinin use in thoracic aortic surgery: Safety and outcomes J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 909 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Cooper Jr, J. Abrams, O.H. Frazier, R. Radovancevic, B. Radovancevic, A. W. Bracey, M. J. Kindo, and I. D. Gregoric Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: Possible association with antifibrinolytic therapy J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 963 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rosner and M. D. Okusa Acute Kidney Injury Associated with Cardiac Surgery Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 19 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Fischer and M. Steinhoff Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries Eur J Cardiothorac Surg, December 1, 2005; 28(6): 801 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Donahue Factor V Leiden and Perioperative Risk Anesth. Analg., June 1, 2004; 98(6): 1623 - 1634. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text] |
||||
![]() |
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr. Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture Card. Surg. Adult, January 1, 2003; 2(2003): 681 - 714. [Full Text] |
||||
![]() |
D. Spielvogel, M. N. Mathur, and R. B. Griepp Aneurysms of the Aortic Arch Card. Surg. Adult, January 1, 2003; 2(2003): 1149 - 1168. [Full Text] |
||||
![]() |
L. G. Svensson, E. M. Nadolny, and W. A. Kimmel Multimodal protocol influence on stroke and neurocognitive deficit prevention after ascending/arch aortic operations Ann. Thorac. Surg., December 1, 2002; 74(6): 2040 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Svensson Progress in ascending and aortic arch surgery: minimally invasive surgery, blood conservation, and neurological deficit prevention Ann. Thorac. Surg., November 1, 2002; 74(5): S1786 - S1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Casati, L. Sandrelli, G. Speziali, G. Calori, M. A. Grasso, and S. Spagnolo Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1084 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shibata, S. Takamoto, Y. Kotsuka, and H. Sato Effectiveness of combined blood conservation measures in thoracic aortic operations with deep hypothermic circulatory arrest Ann. Thorac. Surg., March 1, 2002; 73(3): 739 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Despotis, M. S. Avidan, and C. W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann. Thorac. Surg., November 1, 2001; 72(5): S1821 - S1831. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Mora Mangano, M. J. Neville, P. H. Hsu, I. Mignea, J. King, and D. C. Miller Aprotinin, Blood Loss, and Renal Dysfunction in Deep Hypothermic Circulatory Arrest Circulation, September 18, 2001; 104(2009): I-276 - I-281. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Kouchoukos, P. Masetti, C. K. Rokkas, S. F. Murphy, and E. H. Blackstone Safety and efficacy of hypothermic cardiopulmonary bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta Ann. Thorac. Surg., September 1, 2001; 72(3): 699 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Olsson, A. Siegbahn, E. Halden, B. Nilsson, P. Venge, and S. Thelin No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits Ann. Thorac. Surg., March 1, 2000; 69(3): 743 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. O’Connor, D. V. Brown, M. Avramov, S. Barnes, H. N. O’Connor, and K. J. Tuman The Impact of Renal Dysfunction on Aprotinin Pharmacokinetics During Cardiopulmonary Bypass Anesth. Analg., November 1, 1999; 89(5): 1101 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Smith and T. B. Spanier Aprotinin in deep hypothermic circulatory arrest Ann. Thorac. Surg., July 1, 1999; 68(1): 278 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Westaby Anti-fibrinolytic therapy in thoracic aortic surgery Ann. Thorac. Surg., June 1, 1999; 67(6): 1983 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Hyde, J. A Chinn, and T. R Graham Platelets and cardiopulmonary bypass Perfusion, December 1, 1998; 13(6): 389 - 407. [PDF] |
||||
![]() |
R. G.H. Speekenbrink, R. M. Bertina, F. Espana, C. R.H. Wildevuur, and L. Eijsman Activation of the protein C system during cardiopulmonary bypass with and without aprotinin Ann. Thorac. Surg., December 1, 1998; 66(6): 1998 - 2002. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Rich The efficacy and safety of aprotinin use in cardiac surgery Ann. Thorac. Surg., November 1, 1998; 66(90050): S6 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Miller, S. R. Tosone, V. K.H. Tam, K. R. Kanter, N. A. Guzzetta, J. M. Bailey, and J. H. Levy Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations Ann. Thorac. Surg., August 1, 1998; 66(2): 535 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pouard Review of Efficacy Parameters Ann. Thorac. Surg., June 1, 1998; 65(90060): S40 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cohen, J. Ivanov, R. D. Weisel, V. Rao, M. K. Mohabeer, and D. A. G. Mickle Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss Ann. Thorac. Surg., March 1, 1998; 65(3): 674 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Alvarez, J. Goldstein, J. Mezzatesta, B. Flanagan, and M. Dodd Fatal intraoperative pulmonary thrombosis after graft replacement ofan aneurysm of the arch and descending aorta in association with deephypothermic circulatory arrest and aprotinin therapy J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 723 - 724. [Full Text] [PDF] |
||||
![]() |
M. Ehrlich, M. Grabenwoger, F. Cartes-Zumelzu, D. Luckner, J. Kovarik, G. Laufer, A. Kocher, R. Konetschny, E. Wolner, and M. Havel Operations on the thoracic aorta and hypothermic circulatory arrest: Is aprotinin safe? J. Thorac. Cardiovasc. Surg., January 1, 1998; 115(1): 220 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Westaby Aprotinin Fifteen Years Later Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 366 - 375. [Abstract] [PDF] |
||||
![]() |
N. Hayashida, T. Isomura, T. Sato, H. Maruyama, K. Kosuga, and S. Aoyagi EFFECTS OF MINIMAL-DOSE APROTININ ON CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 261 - 269. [Abstract] [Full Text] |
||||
![]() |
P. K. Smith and L. H. Muhlbaier Aprotinin: Safe and Effective Only With the Full-Dose Regimen Ann. Thorac. Surg., December 1, 1996; 62(6): 1575 - 1577. [Full Text] |
||||
![]() |
S. Cicek, U. Demirkilic, E. Ozal, E. Kuralay, H. Bingol, H. Tatar, and O. Y. Ozturk POSTOPERATIVE USE OF APROTININ IN CARDIAC OPERATIONS: AN ALTERNATIVE TO ITS PROPHYLACTIC USE J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1462 - 1467. [Abstract] [Full Text] |
||||
![]() |
J. S. Tweddell, S. Berger, P. C. Frommelt, A. N. Pelech, D. A. Lewis, R. T. Fedderly, M. A. Frommelt, T. S. McManus, Ccp, K. A. Mussatto, et al. Aprotinin Improves Outcome of Single-Ventricle Palliation Ann. Thorac. Surg., November 1, 1996; 62(5): 1329 - 1335. [Abstract] [Full Text] |
||||
![]() |
A. D. Hilgenberg, C. W. Akins, D. L. Logan, G. J. Vlahakes, M. J. Buckley, J. C. Madsen, and D. F. Torchiana Composite Aortic Root Replacement With Direct Coronary Artery Implantation Ann. Thorac. Surg., October 1, 1996; 62(4): 1090 - 1095. [Abstract] [Full Text] |
||||
![]() |
T. J. Vander Salm, S. Kaur, R. A. Lancey, O. N. Okike, A. T. Pezzella, R. F. Stahl, L. Leone, J.-M. Li, C. R. Valeri, and A. D. Michelson REDUCTION OF BLEEDING AFTER HEART OPERATIONS THROUGH THE PROPHYLACTIC USE OF EPSILON-AMINOCAPROIC ACID J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1098 - 1107. [Abstract] [Full Text] |
||||
![]() |
S. Cicek, U. Demirkilic, E. Kuralay, E. Ozal, and H. Tatar Postoperative Aprotinin: Effect on Blood Loss and Transfusion Requirements in Cardiac Operations Ann. Thorac. Surg., May 1, 1996; 61(5): 1372 - 1376. [Abstract] [Full Text] |
||||
![]() |
R. M. Bojar, D. D. Payne, R. E. Murphy, S. L. Schwartz, J. R. Belden, L. R. Caplan, and H. Rastegar Surgical Treatment of Systemic Atheroembolism From the Thoracic Aorta Ann. Thorac. Surg., May 1, 1996; 61(5): 1389 - 1393. [Abstract] [Full Text] |
||||
![]() |
M. J. Moulton, L. L. Creswell, M. E. Mackey, J. L. Cox, and M. Rosenbloom REEXPLORATION FOR BLEEDING IS A RISK FACTOR FOR ADVERSE OUTCOMES AFTER CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 1037 - 1046. [Abstract] [Full Text] |
||||
![]() |
S. K. Ohri, R. Paratt, J. M. Becket, J. Brannan, B. J. Hunt, and K. M. Taylor Genetically Engineered Serine Protease Inhibitor for Hemostasis After Cardiac Operations Ann. Thorac. Surg., April 1, 1996; 61(4): 1223 - 1230. [Abstract] [Full Text] |
||||
![]() |
G. J. Despotis, A. L. Alsoufiev, E. Spitznagel, L. T. Goodnough, and D. G. Lappas Response of Kaolin ACT to Heparin: Evaluation With an Automated Assay and Higher Heparin Doses Ann. Thorac. Surg., March 1, 1996; 61(3): 795 - 799. [Abstract] [Full Text] |
||||
![]() |
D. J. Goldstein, C. M. DeRosa, L. B. Mongero, A. D. Weinberg, R. E. Michler, E. A. Rose, M. C. Oz, and C. R. Smith SAFETY AND EFFICACY OF APROTININ UNDER CONDITIONS OF DEEP HYPOTHERMIA AND CIRCULATORY ARREST J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1615 - 1622. [Abstract] [Full Text] |
||||
![]() |
P. R. Feindt, S. Walcher, I. Volkmer, H. E. Keller, U. Straub, H. Huwer, U. T. Seyfert, T. Petzold, and E. Gams Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting Ann. Thorac. Surg., October 1, 1995; 60(4): 1076 - 1080. [Abstract] [PDF] |
||||
![]() |
A. Wahba, A. Philip, M. Bauer, M. Kaiser, H. Aebert, and D. Birnbaum The blood saving potential of vortex versus roller pump with and without aprotinin Perfusion, September 1, 1995; 10(5): 333 - 341. [Abstract] [PDF] |
||||
![]() |
N. T. Kouchoukos, B. B. Daily, C. K. Rokkas, S. F. Murphy, S. Bauer, and N. Abboud Hypothermic bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta Ann. Thorac. Surg., July 1, 1995; 60(1): 67 - 77. [Abstract] [PDF] |
||||
![]() |
L. G. Svensson, J. Sun, E. Nadolny, and W. A. Kimmel Prospective evaluation of minimal blood use for ascending aorta and aortic arch operations Ann. Thorac. Surg., June 1, 1995; 59(6): 1501 - 1508. [Abstract] [PDF] |
||||
![]() |
G. J. Despotis, J. H. Joist, D. Joiner-Maier, A. L. Alsoufiev, A. N. Triantafillou, L. T. Goodnough, S. A. Santoro, and D. G. Lappas Effect of aprotinin on activated clotting time whole blood and plasma heparin measurements Ann. Thorac. Surg., January 1, 1995; 59(1): 106 - 111. [Abstract] [PDF] |
||||
![]() |
J. H. Lemmer Jr, W. Stanford, S. L. Bonney, E. V. Chomka, R. B. Karp, G. W. Laub, J. A. Rumberger, and H. V. Schaff Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function Ann. Thorac. Surg., January 1, 1995; 59(1): 132 - 136. [Abstract] [PDF] |
||||
![]() |
B. Blauhut, W. Harringer, P. Bettelheim, J. E. Doran, P. Spath, and P. Lundsgaard-Hansen Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1083 - 1091. [Abstract] [Full Text] |
||||
![]() |
D. J. O'Regan, N. Giannopoulos, N. Mediratta, S. W. H. Kendall, A. Forni, R. Pillai, and S. Westaby Topical aprotinin in cardiac operations Ann. Thorac. Surg., September 1, 1994; 58(3): 778 - 781. [Abstract] [PDF] |
||||
![]() |
N. T. Kouchoukos, T. M. Sundi III, and I. E. Saffitz Reply Ann. Thorac. Surg., August 1, 1994; 58(2): 607 - 608. [PDF] |
||||
![]() |
J. Boldt, B. Zickmann, E.Schindler, A. Welters, F. Dapper, and G. Hempelmann Influence of aprotinin on the thrombomodulin/ protein C system in pediatric cardiac operations J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1215 - 1221. [Abstract] [Full Text] |
||||
![]() |
W. M. DeCampli, D. Goodwin, J. C. Kosek, C. E. Handen, R. S. Mitchell, D. C. Miller, and A. DeAnda Jr Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs Ann. Thorac. Surg., March 1, 1994; 57(3): 778 - 780. [Abstract] [PDF] |
||||
![]() |
M. Ranucci, M. Pavesi, E. Mazza, C. Bertucci, A. Frigiola, L. Menicanti, A. Ditta, A. Boncilli, and D. Conti Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique Perfusion, January 1, 1994; 9(5): 319 - 326. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |